Bluebirdagereversal

Shutdown

Website unreachable since Oct 22, 2026

BlueBird provides a non-genetic, autologous therapy designed to reverse biological age by rebalancing cellular signaling pathways. This protocol targets multiple hallmarks of aging, delivering measurable rejuvenation through a safe, clinic-ready treatment. The service aims to extend healthspan by directly addressing the biology of aging via a standardized, scalable process.

Traction –/10

HQ unknown

Updated 5 months ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

BlueBird provides a non-genetic, autologous protocol designed to safely rebalance cellular signaling associated with aging. This therapy targets multiple hallmarks of aging to deliver measurable biological rejuvenation and extend healthspan. The clinic-ready process integrates into existing longevity centers for scalable deployment worldwide.